We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Company Withdraws Parkinson’s Drug Due to Heart Valve Damage
Company Withdraws Parkinson’s Drug Due to Heart Valve Damage
March 29, 2007
Valeant is withdrawing its Parkinson’s disease medication Permax because of the increased risk of heart valve damage, the FDA announced.